Progressive brain atrophy and white matter changes in MOG encephalomyelitis

Neurology. 2020 Sep 1;95(9):402-403. doi: 10.1212/WNL.0000000000010403. Epub 2020 Jul 20.

Authors

Young Nam Kwon¹, Jae Ho Jung¹, Seong-Joon Kim², Jung-Joon Sung¹, Sung-Min Kim²

Affiliations

¹ From the Department of Neurology (Y.N.K., J.-J.S., S.-M.K.) and Departments of Ophthalmology (J.H.J., S.-J.K.) and Neurology (J.-J.S., S.-M.K.), College of Medicine, Seoul National University, Seoul National University Hospital; and Department of Neurology (Y.N.K.), The Catholic University of Korea, Eunpyeong St. Mary's Hospital, Korea.
² From the Department of Neurology (Y.N.K., J.-J.S., S.-M.K.) and Departments of Ophthalmology (J.H.J., S.-J.K.) and Neurology (J.-J.S., S.-M.K.), College of Medicine, Seoul National University, Seoul National University Hospital; and Department of Neurology (Y.N.K.), The Catholic University of Korea, Eunpyeong St. Mary's Hospital, Korea. sueh916@gmail.com.

PMID: 32690792
DOI: 10.1212/WNL.0000000000010403

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Adrenal Cortex Hormones / therapeutic use
Adult
Atrophy
Autoantibodies / immunology*
Autoimmune Diseases of the Nervous System / diagnostic imaging*
Autoimmune Diseases of the Nervous System / immunology
Autoimmune Diseases of the Nervous System / therapy
Brain / diagnostic imaging*
Brain / pathology
Disease Progression
Encephalomyelitis / diagnostic imaging*
Encephalomyelitis / immunology
Encephalomyelitis / therapy
Humans
Immunoglobulins, Intravenous / therapeutic use
Immunologic Factors / therapeutic use
Magnetic Resonance Imaging
Male
Mycophenolic Acid / therapeutic use
Myelin-Oligodendrocyte Glycoprotein / immunology*

Substances

Adrenal Cortex Hormones
Autoantibodies
Immunoglobulins, Intravenous
Immunologic Factors
Myelin-Oligodendrocyte Glycoprotein
Mycophenolic Acid